Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)

SHE:301075 Statistics

Total Valuation

SHE:301075 has a market cap or net worth of CNY 4.94 billion. The enterprise value is 5.25 billion.

Market Cap	4.94B
Enterprise Value	5.25B

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:301075 has 78.96 million shares outstanding. The number of shares has decreased by -1.83% in one year.

Current Share Class	78.96M
Shares Outstanding	78.96M
Shares Change (YoY)	-1.83%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	5.44%
Float	26.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.90
PB Ratio	7.71
P/TBV Ratio	9.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-41.93
EV / Sales	29.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-33.65

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.58.

Current Ratio	1.16
Quick Ratio	0.89
Debt / Equity	0.58
Debt / EBITDA	n/a
Debt / FCF	-2.38
Interest Coverage	-39.56

Financial Efficiency

Return on equity (ROE) is -24.33% and return on invested capital (ROIC) is -17.99%.

Return on Equity (ROE)	-24.33%
Return on Assets (ROA)	-7.13%
Return on Invested Capital (ROIC)	-17.99%
Return on Capital Employed (ROCE)	-14.85%
Weighted Average Cost of Capital (WACC)	4.98%
Revenue Per Employee	356,350
Profits Per Employee	-252,144
Employee Count	497
Asset Turnover	0.14
Inventory Turnover	2.57

Taxes

In the past 12 months, SHE:301075 has paid 425,416 in taxes.

Income Tax	425,416
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +244.13% in the last 52 weeks. The beta is 0.19, so SHE:301075's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+244.13%
50-Day Moving Average	55.63
200-Day Moving Average	41.21
Relative Strength Index (RSI)	55.81
Average Volume (20 Days)	1,395,336

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301075 had revenue of CNY 177.11 million and -125.32 million in losses. Loss per share was -1.61.

Revenue	177.11M
Gross Profit	16.43M
Operating Income	-143.52M
Pretax Income	-170.74M
Net Income	-125.32M
EBITDA	-110.51M
EBIT	-143.52M
Loss Per Share	-1.61

Balance Sheet

The company has 333.44 million in cash and 370.91 million in debt, with a net cash position of -37.48 million or -0.47 per share.

Cash & Cash Equivalents	333.44M
Total Debt	370.91M
Net Cash	-37.48M
Net Cash Per Share	-0.47
Equity (Book Value)	640.68M
Book Value Per Share	7.44
Working Capital	79.29M

Cash Flow

In the last 12 months, operating cash flow was -72.55 million and capital expenditures -83.60 million, giving a free cash flow of -156.15 million.

Operating Cash Flow	-72.55M
Capital Expenditures	-83.60M
Free Cash Flow	-156.15M
FCF Per Share	-1.98

Margins

Gross margin is 9.28%, with operating and profit margins of -81.04% and -70.76%.

Gross Margin	9.28%
Operating Margin	-81.04%
Pretax Margin	-96.41%
Profit Margin	-70.76%
EBITDA Margin	-62.40%
EBIT Margin	-81.04%
FCF Margin	n/a

Dividends & Yields

SHE:301075 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.83%
Shareholder Yield	1.83%
Earnings Yield	-2.54%
FCF Yield	-3.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1